Grace Therapeutics (GRCE) Total Non-Current Liabilities (2019 - 2025)
Grace Therapeutics (GRCE) posted Total Non-Current Liabilities of $3.56 million for fiscal Q2 2026 (quarter ended Sep 30, 2025), down 46.2% from $6.61 million a year earlier and down 23.1% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends
At the end of FY2025 (ended Mar 31, 2025), Grace Therapeutics' Total Non-Current Liabilities came in at $4.24 million, down 41.1% from FY2024.
- Annual Total Non-Current Liabilities has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- In prior fiscal years, Grace Therapeutics' Total Non-Current Liabilities was $7.2 million in FY2024 (-35.5%), $11.17 million in FY2023 (-45.1%), $20.34 million in FY2022 and $1.58 million in FY2021 (-78.9%).
- The fiscal Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since fiscal Q3 2022.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last five quarters, with an average decline of 38.9% over the last seven quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q3 2023, with growth of 593.2%; the weakest was fiscal Q4 2021, with a decline of 78.9%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $4.63 million (Q1 2026), $4.24 million (Q4 2025) and $5.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 616.05 Bn | 534.58 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 500.90 Bn | 474.01 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 367.17 Bn | 321.54 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 235.77 Bn | 191.17 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.70 Bn | 164.90 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Grace Therapeutics | 34.37 Mn | -31.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 4.63 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 5.30 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 8.17 Mn |
| Sep 30, 2023 | 8.01 Mn |
| Mar 31, 2023 | 11.17 Mn |
| Dec 31, 2022 | 20.08 Mn |
| Sep 30, 2022 | 20.75 Mn |
| Mar 31, 2022 | 20.34 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 4.48 Mn |
| Jun 30, 2021 | 2.35 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Dec 31, 2020 | 2.25 Mn |
| Sep 30, 2020 | 3.79 Mn |
| Jun 30, 2020 | 6.04 Mn |
API Access
Grace Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();